Biofrontera Inc. Deferred Federal Income Tax Expense (Benefit)
Biofrontera Inc. (BFRI) reported Deferred Federal Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-19
- Biofrontera Inc. deferred federal income tax expense (benefit) for the quarter ending 2023-03-31 was $0.00.
- Biofrontera Inc. deferred federal income tax expense (benefit) for the quarter ending 2022-12-31 was $0.00.
- Biofrontera Inc. deferred federal income tax expense (benefit) for the quarter ending 2022-09-30 was $0.00.
- Biofrontera Inc. deferred federal income tax expense (benefit) for the quarter ending 2022-06-30 was $0.00.
- Biofrontera Inc. deferred federal income tax expense (benefit) for fiscal 2025 was $0.00.
- Biofrontera Inc. deferred federal income tax expense (benefit) for fiscal 2024 was $0.00.
- Biofrontera Inc. deferred federal income tax expense (benefit) for fiscal 2023 was $0.00.
- Biofrontera Inc. deferred federal income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Deferred Federal Income Tax Expense (Benefit) 3 month | Deferred Federal Income Tax Expense (Benefit) 6 month | Deferred Federal Income Tax Expense (Benefit) 9 month | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 24 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-19 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-19 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2024-03-15 | $0.00 derived: sum of 3 quarters · filed 2024-03-15 | $0.00 derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $0.00 derived: sum of 2 quarters · filed 2024-03-15 | $0.00 derived: sum of 3 quarters · filed 2024-03-15 | $0.00 10-K · filed 2024-03-15 | $0.00 8-K · filed 2023-10-03 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | $0.00 8-K · filed 2023-10-03 | ||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |